Nikolas Pontikos, William A. Woof, Siying Lin, Biraja Ghoshal, Bernardo S. Mendes, Advaith Veturi, Quang Nguyen, Behnam Javanmardi, Michalis Georgiou, Alexander Hustinx, Miguel A. Ibarra-Arellano, Ismail Moghul, Yichen Liu, Kristina Pfau, Maximilian Pfau, Mital Shah, Jing Yu, Saoud Al-Khuzaei, Siegfried K. Wagner, Malena Daich Varela, Thales Antonio Cabral de Guimarães, Sagnik Sen, Gunjan Naik, Dayyanah Sumodhee, Dun Jack Fu, Nathaniel Kabiri, Jennifer Furman, Bart Liefers, Aaron Y. Lee, Samantha R. De Silva, Caio Marques, Fabiana Motta, Yu Fujinami-Yokokawa, Alison J. Hardcastle, Gavin Arno, Birgit Lorenz, Philipp Herrmann, Kaoru Fujinami, Juliana Sallum, Savita Madhusudhan, Susan M. Downes, Frank G. Holz, Konstantinos Balaskas, Andrew R. Webster, Omar A. Mahroo, Peter M. Krawitz, Michel Michaelides
{"title":"利用Eye2Gene多模态成像研究遗传性视网膜疾病的下一代表型","authors":"Nikolas Pontikos, William A. Woof, Siying Lin, Biraja Ghoshal, Bernardo S. Mendes, Advaith Veturi, Quang Nguyen, Behnam Javanmardi, Michalis Georgiou, Alexander Hustinx, Miguel A. Ibarra-Arellano, Ismail Moghul, Yichen Liu, Kristina Pfau, Maximilian Pfau, Mital Shah, Jing Yu, Saoud Al-Khuzaei, Siegfried K. Wagner, Malena Daich Varela, Thales Antonio Cabral de Guimarães, Sagnik Sen, Gunjan Naik, Dayyanah Sumodhee, Dun Jack Fu, Nathaniel Kabiri, Jennifer Furman, Bart Liefers, Aaron Y. Lee, Samantha R. De Silva, Caio Marques, Fabiana Motta, Yu Fujinami-Yokokawa, Alison J. Hardcastle, Gavin Arno, Birgit Lorenz, Philipp Herrmann, Kaoru Fujinami, Juliana Sallum, Savita Madhusudhan, Susan M. Downes, Frank G. Holz, Konstantinos Balaskas, Andrew R. Webster, Omar A. Mahroo, Peter M. Krawitz, Michel Michaelides","doi":"10.1038/s42256-025-01040-8","DOIUrl":null,"url":null,"abstract":"<p>Rare eye diseases such as inherited retinal diseases (IRDs) are challenging to diagnose genetically. IRDs are typically monogenic disorders and represent a leading cause of blindness in children and working-age adults worldwide. A growing number are now being targeted in clinical trials, with approved treatments increasingly available. However, access requires a genetic diagnosis to be established sufficiently early. Critically, the timely identification of a genetic cause remains challenging. We demonstrate that a deep learning algorithm, Eye2Gene, trained on a large multimodal imaging dataset of individuals with IRDs (<i>n</i> = 2,451) and externally validated on data provided by five different clinical centres, provides better-than-expert-level top-five accuracy of 83.9% for supporting genetic diagnosis for the 63 most common genetic causes. We demonstrate that Eye2Gene’s next-generation phenotyping can increase diagnostic yield by improving screening for IRDs, phenotype-driven variant prioritization and automatic similarity matching in phenotypic space to identify new genes. Eye2Gene is accessible online (app.eye2gene.com) for research purposes.</p>","PeriodicalId":48533,"journal":{"name":"Nature Machine Intelligence","volume":"6 1","pages":""},"PeriodicalIF":18.8000,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Next-generation phenotyping of inherited retinal diseases from multimodal imaging with Eye2Gene\",\"authors\":\"Nikolas Pontikos, William A. Woof, Siying Lin, Biraja Ghoshal, Bernardo S. Mendes, Advaith Veturi, Quang Nguyen, Behnam Javanmardi, Michalis Georgiou, Alexander Hustinx, Miguel A. Ibarra-Arellano, Ismail Moghul, Yichen Liu, Kristina Pfau, Maximilian Pfau, Mital Shah, Jing Yu, Saoud Al-Khuzaei, Siegfried K. Wagner, Malena Daich Varela, Thales Antonio Cabral de Guimarães, Sagnik Sen, Gunjan Naik, Dayyanah Sumodhee, Dun Jack Fu, Nathaniel Kabiri, Jennifer Furman, Bart Liefers, Aaron Y. Lee, Samantha R. De Silva, Caio Marques, Fabiana Motta, Yu Fujinami-Yokokawa, Alison J. Hardcastle, Gavin Arno, Birgit Lorenz, Philipp Herrmann, Kaoru Fujinami, Juliana Sallum, Savita Madhusudhan, Susan M. Downes, Frank G. Holz, Konstantinos Balaskas, Andrew R. Webster, Omar A. Mahroo, Peter M. Krawitz, Michel Michaelides\",\"doi\":\"10.1038/s42256-025-01040-8\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Rare eye diseases such as inherited retinal diseases (IRDs) are challenging to diagnose genetically. IRDs are typically monogenic disorders and represent a leading cause of blindness in children and working-age adults worldwide. A growing number are now being targeted in clinical trials, with approved treatments increasingly available. However, access requires a genetic diagnosis to be established sufficiently early. Critically, the timely identification of a genetic cause remains challenging. We demonstrate that a deep learning algorithm, Eye2Gene, trained on a large multimodal imaging dataset of individuals with IRDs (<i>n</i> = 2,451) and externally validated on data provided by five different clinical centres, provides better-than-expert-level top-five accuracy of 83.9% for supporting genetic diagnosis for the 63 most common genetic causes. We demonstrate that Eye2Gene’s next-generation phenotyping can increase diagnostic yield by improving screening for IRDs, phenotype-driven variant prioritization and automatic similarity matching in phenotypic space to identify new genes. Eye2Gene is accessible online (app.eye2gene.com) for research purposes.</p>\",\"PeriodicalId\":48533,\"journal\":{\"name\":\"Nature Machine Intelligence\",\"volume\":\"6 1\",\"pages\":\"\"},\"PeriodicalIF\":18.8000,\"publicationDate\":\"2025-06-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nature Machine Intelligence\",\"FirstCategoryId\":\"94\",\"ListUrlMain\":\"https://doi.org/10.1038/s42256-025-01040-8\",\"RegionNum\":1,\"RegionCategory\":\"计算机科学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Machine Intelligence","FirstCategoryId":"94","ListUrlMain":"https://doi.org/10.1038/s42256-025-01040-8","RegionNum":1,"RegionCategory":"计算机科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE","Score":null,"Total":0}
Next-generation phenotyping of inherited retinal diseases from multimodal imaging with Eye2Gene
Rare eye diseases such as inherited retinal diseases (IRDs) are challenging to diagnose genetically. IRDs are typically monogenic disorders and represent a leading cause of blindness in children and working-age adults worldwide. A growing number are now being targeted in clinical trials, with approved treatments increasingly available. However, access requires a genetic diagnosis to be established sufficiently early. Critically, the timely identification of a genetic cause remains challenging. We demonstrate that a deep learning algorithm, Eye2Gene, trained on a large multimodal imaging dataset of individuals with IRDs (n = 2,451) and externally validated on data provided by five different clinical centres, provides better-than-expert-level top-five accuracy of 83.9% for supporting genetic diagnosis for the 63 most common genetic causes. We demonstrate that Eye2Gene’s next-generation phenotyping can increase diagnostic yield by improving screening for IRDs, phenotype-driven variant prioritization and automatic similarity matching in phenotypic space to identify new genes. Eye2Gene is accessible online (app.eye2gene.com) for research purposes.
期刊介绍:
Nature Machine Intelligence is a distinguished publication that presents original research and reviews on various topics in machine learning, robotics, and AI. Our focus extends beyond these fields, exploring their profound impact on other scientific disciplines, as well as societal and industrial aspects. We recognize limitless possibilities wherein machine intelligence can augment human capabilities and knowledge in domains like scientific exploration, healthcare, medical diagnostics, and the creation of safe and sustainable cities, transportation, and agriculture. Simultaneously, we acknowledge the emergence of ethical, social, and legal concerns due to the rapid pace of advancements.
To foster interdisciplinary discussions on these far-reaching implications, Nature Machine Intelligence serves as a platform for dialogue facilitated through Comments, News Features, News & Views articles, and Correspondence. Our goal is to encourage a comprehensive examination of these subjects.
Similar to all Nature-branded journals, Nature Machine Intelligence operates under the guidance of a team of skilled editors. We adhere to a fair and rigorous peer-review process, ensuring high standards of copy-editing and production, swift publication, and editorial independence.